US equities
|
NVDA
$151.17
▼-2.76%
MU
$699.29
▼-1.84%
AMD
$523.38
▲+3.97%
SPCX
$144.05
▲+1.66%
SNDK
$766.89
▼-3.81%
TSLA
$383.29
▲+0.84%
AMZN
$267.46
▲+3.71%
AAPL
$352.62
▲+0.20%
NVDA
$151.17
▼-2.76%
MU
$699.29
▼-1.84%
AMD
$523.38
▲+3.97%
SPCX
$144.05
▲+1.66%
SNDK
$766.89
▼-3.81%
TSLA
$383.29
▲+0.84%
AMZN
$267.46
▲+3.71%
AAPL
$352.62
▲+0.20%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Mark Dato
Recent news which mentions Mark Dato
CincyTech-backed Eikonoklastes Therapeutics receives FDA approval for first-in-class ALS treatment
November 09, 2022
Tickers
INNO
Tags
Startups
Mark Dato
Biotech
From
Business Journals